| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000267212.1 |
Pazopanib |
Bladder urothelial carcinoma |
0.028727596 |
Resistant |
| ENSG00000267212.1 |
Pazopanib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044702803 |
Sensitive |
| ENSG00000267212.1 |
Pazopanib |
Skin cutaneous melanoma |
0.033936354 |
Sensitive |
